Skip to main content

Calidi Biotherapeutics, Inc.

CLDI
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855485

No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.

Other share classesCLDWW

13F holders, Q2 2023

Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
25
−2 vs. Q1 2023
Shares held
3.83M
−635.4K (−14.2%) vs. Q1 2023
Total value
$40.6M
−$5.15M (−11.3%) vs. Q1 2023
New holders
3
4 more added
Sold out
5
4 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 25 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 27 institutionsQ1 2022: 40 institutionsQ2 2022: 42 institutionsQ3 2022: 21 institutionsQ4 2022: 25 institutionsQ1 2023: 27 institutionsQ2 2023: 25 institutionsQ3 2023: 13 institutionsQ4 2023: 25 institutionsQ1 2024: 31 institutionsQ2 2024: 32 institutionsQ3 2024: 20 institutionsQ4 2024: 33 institutionsQ1 2025: 36 institutionsQ2 2025: 35 institutionsQ3 2025: 22 institutionsQ4 2025: 27 institutionsQ1 2026: 28 institutionsQ2 2026: 23 institutions
Value heldQ2 2023: $40.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $184.1MQ1 2022: $202.4MQ2 2022: $214.8MQ3 2022: $36.1MQ4 2022: $39.6MQ1 2023: $45.8MQ2 2023: $40.6MQ3 2023: $3.54MQ4 2023: $3.29MQ1 2024: $1.56MQ2 2024: $523.2KQ3 2024: $363.4KQ4 2024: $1.27MQ1 2025: $3.09MQ2 2025: $656.8KQ3 2025: $353.6KQ4 2025: $524.7KQ1 2026: $478.8KQ2 2026: $89.3K
Institutions holding CLDI and their total value by quarter
QuarterHoldersValue
Q2 202623$89.3K
Q1 202628$478.8K
Q4 202527$524.7K
Q3 202522$353.6K
Q2 202535$656.8K
Q1 202536$3.09M
Q4 202433$1.27M
Q3 202420$363.4K
Q2 202432$523.2K
Q1 202431$1.56M
Q4 202325$3.29M
Q3 202313$3.54M
Q2 202325$40.6M
Q1 202327$45.8M
Q4 202225$39.6M
Q3 202221$36.1M
Q2 202242$214.8M
Q1 202240$202.4M
Q4 202127$184.1M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2023.

Institutions holding CLDI in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Hudson Bay Capital Management LP500,000$5.25M0.05%−500,000−50.0%Reduced
Polar Asset Management Partners Inc.412,800$4.33M0.09%00.0%Unchanged
Woodline Partners LP400,000$4.20M0.05%00.0%Unchanged
Kim, LLC356,098$3.74M0.32%00.0%Unchanged
Spartan Fund Management Inc.252,500$3.20M0.78%+102,500+68.3%Added
683 Capital Management, LLC300,000$3.15M0.31%00.0%Unchanged
Clear Street LLC214,318$2.25M0.05%+213,228+19,562.2%Added
Cubist Systematic Strategies, LLC202,272$2.12M0.02%00.0%Unchanged
Bank of Montreal191,000$2.01M0.00%−6,525−3.3%Reduced
Elequin Capital LP169,400$1.78M0.91%00.0%Unchanged
Quarry LP159,802$1.68M1.09%+159,802New
Deutsche Bank AG139,494$1.46M0.00%00.0%Unchanged
Highbridge Capital Management LLC125,000$1.31M0.08%00.0%Unchanged
PenderFund Capital Management Ltd.66,323$922.0K0.29%00.0%Unchanged
Driehaus Capital Management LLC68,127$714.7K0.01%00.0%Unchanged
Boothbay Fund Management, LLC43,987$461.4K0.01%+43,987New
Atw Spac Management LLC42,012$440.7K0.31%+42,012New
CNH Partners LLC40,464$424.5K0.02%−65,120−61.7%Reduced
Magnetar Financial LLC63,132$331.1K0.01%00.0%Unchanged
Karpus Management, Inc.24,200$253.9K0.01%00.0%Unchanged
Caas Capital Management LP20,600$216.1K0.10%+1,000+5.1%Added
Rpo LLC13,610$142.8K0.15%+40.0%Added
Commonwealth of Pennsylvania Public School Empls Retrmt Sys13,400$140.6K0.00%00.0%Unchanged
HRT Financial LP10,817$113.0K0.00%00.0%Unchanged
UBS Group AG10$1050.00%−1−9.1%Reduced
Glazer Capital, LLC0$00.00%−374,900−100.0%Sold out
Shaolin Capital Management LLC0$00.00%−200,000−100.0%Sold out
Virtu Financial LLC0$00.00%−30,368−100.0%Sold out
Ergoteles LLC0$00.00%−19,066−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−2,000−100.0%Sold out